Which biologic do patients prefer?

Rheumatoid arthritis patients are much less likely to discontinue biologic treatment if they are prescribed etanercept, according to a meta-analysis of international drug registries.

Data from 100 studies with over 200,000 patients revealed that after three years of biologic therapy, 44% of patients had discontinued treatment.

But the figure was substantially lower for etanercept (35%), compared with infliximab or

Latest

Trending